Health CanadaGeneral Alert
ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, F...
Published: February 16, 2023Recall ID: 72726Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information
Product Description & Identification
ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
Affected Products
ZEJULA (niraparib)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 72726 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/zejula-niraparib-update-maintenance-treatment-recurrent-ovarian-fallopian-tube-or |
| Issue | New safety information |
| Title | ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting |
| Product | ZEJULA (niraparib) |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2023-02-16 |
| Organization | Marketed health products |